SARS-CoV-2 Genome Sequence Obtained from Ethiopia
- PMID: 35112893
- PMCID: PMC8812317
- DOI: 10.1128/mra.01182-21
SARS-CoV-2 Genome Sequence Obtained from Ethiopia
Abstract
The coding-complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome sequences from 15 nasopharyngeal swabs collected in Addis Ababa, Ethiopia, during the period from December 2020 to March 2021 were determined using Illumina MiSeq technology. A sequence analysis identified that the B.1 SARS-CoV-2 lineage was most prevalent with the worrying emergence of B.1.1.7 in June 2021.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, Xiong Y, Cheng Z, Gao S, Liang K, Luo M, Chen T, Song S, Ma Z, Chen X, Zheng R, Cao Q, Wang F, Zhang Y. 2021. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 73:e4208–e4213. doi:10.1093/cid/ciaa270. - DOI - PMC - PubMed
-
- WHO Health Emergency Dashboard WHO (COVID-19) Homepage. WHO, Geneva, Switzerland. https://covid19.who.int/region/afro/country/et.
-
- Baba MM, Bitew M, Fokam J, Lelo EA, Ahidjo A, Asmamaw K, Beloumou GA, Bulimo WD, Buratti E, Chenwi C, Dadi H, D'Agaro P, De Conti L, Fainguem N, Gadzama G, Maiuri P, Majanja J, Meshack W, Ndjolo A, Nkenfou C, Oderinde BS, Opanda SM, Segat L, Stuani C, Symekher SL, Takou D, Tesfaye K, Triolo G, Tuki K, Zacchigna S, Marcello A. 2021. Diagnostic performance of colorimetric RT LAMP for the identification of SARS-CoV-2: a multicentre prospective clinical evaluation in sub-Saharan Africa. EClinicalMedicine 40:101101. doi:10.1016/j.eclinm.2021.101101. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous